WOODCLIFF LAKE, N.J. — The U.S. pharmaceutical subsidiary of Eisai has promoted one of its executives.
Shaji Procida, who previously served as VP finance of Eisai Inc., has been appointed to serve as VP and CFO. In her elevated role, she will have oversight and responsibility for all of Eisai's financial operations in the United States and also will continue to serve as a member of the company's executive committee. Procida has worked at the drug maker since 1998.
"Shaji is a consummate professional who has been a key advisor within our organization," Eisai Inc. president and CEO Lonnel Coats said. "Her expertise and business leadership will continue to ensure our company's financial well-being as well as support our ongoing efforts to achieve our human healthcare mission of helping to improve the lives of patients and their families."